Orchid to Launch Cephalosporin Generics in U.S. by July

The Chennai-based Orchid Chemicals & Pharmaceuticals Ltd, with its ongoing thrust to penetrate into the U.S. generics market, is expecting a significant growth in its export business from the first half the current financial year. The company, which has scheduled to enter the U.S. market with its cephalosporin generics by July 2005, would also focus on other regulated markets for export of generics in the current financial year.

Pharmabiz (http://www.pharmabiz.com/article/detnews.asp?articleid=27380)